Back to Journals » Clinical Epidemiology » Volume 15

Screening History and 7-Year Survival in 32,099 Colorectal Cancer Patients: A Population-Based Cohort Study [Letter]

Authors Wardoyo S , Anwar T

Received 24 November 2023

Accepted for publication 5 December 2023

Published 7 December 2023 Volume 2023:15 Pages 1171—1172

DOI https://doi.org/10.2147/CLEP.S451619

Checked for plagiarism Yes

Editor who approved publication: Professor Vera Ehrenstein



Slamet Wardoyo,1 Taufik Anwar2

1Department of Environmental Health, Poltekkes Kemenkes Surabaya, Surabaya, Indonesia; 2Department of Environmental Health, Poltekkes Kemenkes Pontianak, Pontianak, Indonesia

Correspondence: Slamet Wardoyo, Tel +62 857 8754 9486, Email [email protected]


View the original paper by Mr Hsiao and colleagues

A Response to Letter has been published for this article.


Dear editor

We am writing to comment on the article titled “Screening History and 7-Year Survival in 32,099 Colorectal Cancer Patients: A Population-Based Cohort Study” by Bo-Yu Hsiao et al, published in Clinical Epidemiology 2023:15. The study provides valuable insights into the screening history and survival outcomes of colorectal cancer patients.1 This study used sensitivity analysis to assess the stability of the results, adjusted for various colorectal cancer staging systems, and accounted for common biases in screening impact studies, demonstrating a robust methodology. This study provides important insights into the impact of screening history on the survival of colorectal cancer patients, and contributes to the existing knowledge in this field.

Despite the advantages, we would like to criticize this study for its lack of detailed information regarding patient demographics, comorbidities, and treatment modalities. More detailed information regarding these factors could provide a more comprehensive understanding of the factors affecting colon cancer patient survival. Also, the study did not address the potential impact of lifestyle factors, such as diet and physical activity, on colon cancer survival. Furthermore, the study did not explore potential solutions to overcome barriers such as lack of patient awareness, limited health services, and financial constraints that affect participation in screening and follow-up examinations. Thus, this study has weaknesses in terms of the depth of analysis of factors affecting colon cancer patient survival and the lack of exploration of solutions to overcome related barriers.

To improve the quality of future studies, it is recommended to explore more detailed information regarding patient demographics, comorbidities, and treatment modalities in relation to colon cancer patient survival. In addition, future studies can expand the scope by considering the influence of lifestyle factors, such as diet, physical activity level, and smoking habits, on patient survival. In addition, it is important to explore solutions to overcome barriers identified in this study, such as lack of patient awareness, limited health services, and financial constraints that affect participation in screening and follow-up examinations. Future studies could also expand the analysis by considering the costs and benefits of different screening methods and interventions to overcome these barriers. Thus, future research is expected to provide a more comprehensive understanding and more effective solutions regarding colon cancer management.2,3

In conclusion, the study by Hsiao et al provides valuable insights into the screening history and survival outcomes of colorectal cancer patients. Addressing the identified weaknesses and implementing the recommendations can further enhance the impact of future research in this field.

Disclosure

The authors report no conflicts of interest in this communication.

References

1. Hsiao BY, Chiang CJ, Yang YW, Lin LJ, Hsu TH, Lee WC. Screening history and 7-year survival in 32,099 colorectal cancer patients: a population-based cohort study. Clin Epidemiol. 2023;1009–1025. doi:10.2147/CLEP.S424918

2. Stuart EA, Cole SR, Bradshaw CP, Leaf PJ. The use of propensity scores to assess the generalizability of results from randomized trials. J R Stat Soc Ser a Stat Soc. 2011;174(2):369–386. doi:10.1111/j.1467-985X.2010.00673.x

3. Green LW, Glasgow RE. Evaluating the relevance, generalization, and applicability of research: issues in external validation and translation methodology. Eval Health Prof. 2006;29(1):126–153. doi:10.1177/0163278705284445

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.